ASML vs ZNTL · P/E 57, $665.37B cap vs $257.7M cap
ASML Holding NV ADR (ASML) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
ASML does not have a complete income-statement cache yet.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the ASML and ZNTL stock pages for the full models.
Not investment advice.